Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3525 USD | +2.78% | +3.80% | +109.82% |
04-02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 | |
04-01 | BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 19.05M 26.03M | Sales 2025 * | 25.76M 35.22M | Capitalization | 104M 143M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.37M | Net income 2025 * | - 0 | EV / Sales 2024 * | 5.48 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.05 x |
P/E ratio 2024 * |
-35.3
x | P/E ratio 2025 * |
-
| Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.75% |
Latest transcript on BioLargo, Inc.
1 day | +2.78% | ||
1 week | +3.80% | ||
Current month | -0.68% | ||
1 month | +4.69% | ||
3 months | +64.34% | ||
6 months | +114.16% | ||
Current year | +109.82% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Director of Finance/CFO | 68 | 08-01-31 | |
Chief Operating Officer | 55 | 02-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.3525 | +2.78% | 224,392 |
24-04-25 | 0.343 | -2.01% | 89,426 |
24-04-24 | 0.35 | -0.43% | 246,564 |
24-04-23 | 0.3515 | +4.93% | 122,885 |
24-04-22 | 0.335 | -1.36% | 179,674 |
Delayed Quote OTC Markets, April 26, 2024 at 03:25 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+109.82% | 104M | |
+5.14% | 103B | |
-5.63% | 63.04B | |
+39.52% | 39.06B | |
+12.91% | 37.58B | |
+7.41% | 33.24B | |
+6.85% | 19.22B | |
+12.86% | 16.83B | |
+7.73% | 15.03B | |
+16.93% | 14.96B |
- Stock Market
- Equities
- BLGO Stock